272 related articles for article (PubMed ID: 26171588)
1. TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals.
Wang F; Hou H; Wu S; Tang Q; Liu W; Huang M; Yin B; Huang J; Mao L; Lu Y; Sun Z
Eur J Immunol; 2015 Oct; 45(10):2886-97. PubMed ID: 26171588
[TBL] [Abstract][Full Text] [Related]
2. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.
Li M; Xia P; Du Y; Liu S; Huang G; Chen J; Zhang H; Hou N; Cheng X; Zhou L; Li P; Yang X; Fan Z
J Biol Chem; 2014 Jun; 289(25):17647-57. PubMed ID: 24817116
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
Front Immunol; 2018; 9():2341. PubMed ID: 30364127
[TBL] [Abstract][Full Text] [Related]
4. T-cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis.
Bi J; Zhang Q; Liang D; Xiong L; Wei H; Sun R; Tian Z
Hepatology; 2014 May; 59(5):1715-25. PubMed ID: 24319005
[TBL] [Abstract][Full Text] [Related]
5. TIGIT safeguards liver regeneration through regulating natural killer cell-hepatocyte crosstalk.
Bi J; Zheng X; Chen Y; Wei H; Sun R; Tian Z
Hepatology; 2014 Oct; 60(4):1389-98. PubMed ID: 24912841
[TBL] [Abstract][Full Text] [Related]
6. Galectin-9 Expression Defines a Subpopulation of NK Cells with Impaired Cytotoxic Effector Molecules but Enhanced IFN-γ Production, Dichotomous to TIGIT, in HIV-1 Infection.
Motamedi M; Shahbaz S; Fu L; Dunsmore G; Xu L; Harrington R; Houston S; Elahi S
Immunohorizons; 2019 Nov; 3(11):531-546. PubMed ID: 31732662
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth
Zhou XM; Li WQ; Wu YH; Han L; Cao XG; Yang XM; Wang HF; Zhao WS; Zhai WJ; Qi YM; Gao YF
Front Immunol; 2018; 9():2821. PubMed ID: 30555485
[TBL] [Abstract][Full Text] [Related]
8. PD-1, CTLA-4, LAG-3, and TIGIT: The roles of immune checkpoint receptors on the regulation of human NK cell phenotype and functions.
Esen F; Deniz G; Aktas EC
Immunol Lett; 2021 Dec; 240():15-23. PubMed ID: 34599946
[TBL] [Abstract][Full Text] [Related]
9. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.
Vendrame E; Seiler C; Ranganath T; Zhao NQ; Vergara R; Alary M; Labbé AC; Guédou F; Poudrier J; Holmes S; Roger M; Blish CA
AIDS; 2020 May; 34(6):801-813. PubMed ID: 32028328
[TBL] [Abstract][Full Text] [Related]
10. TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT.
Nakamura Y; Naito K; Yamashita-Kanemaru Y; Komori D; Hirochika R; Shibuya A; Shibuya K
Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):105-109. PubMed ID: 29648914
[TBL] [Abstract][Full Text] [Related]
11. Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.
Sarhan D; Cichocki F; Zhang B; Yingst A; Spellman SR; Cooley S; Verneris MR; Blazar BR; Miller JS
Cancer Res; 2016 Oct; 76(19):5696-5706. PubMed ID: 27503932
[TBL] [Abstract][Full Text] [Related]
12. Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection.
Zhang C; Wang H; Li J; Hou X; Li L; Wang W; Shi Y; Li D; Li L; Zhao Z; Li L; Aji T; Lin R; Shao Y; Vuitton DA; Tian Z; Sun H; Wen H
Hepatology; 2021 Dec; 74(6):3376-3393. PubMed ID: 34192365
[TBL] [Abstract][Full Text] [Related]
13. TIGIT Signaling Pathway Regulates Natural Killer Cell Function in Chronic Hepatitis B Virus Infection.
Wang J; Hou H; Mao L; Wang F; Yu J; Luo Y; Lin Q; Sun Z
Front Med (Lausanne); 2021; 8():816474. PubMed ID: 35265633
[TBL] [Abstract][Full Text] [Related]
14. TIGIT immune checkpoint blockade enhances immunity of human peripheral blood NK cells against castration-resistant prostate cancer.
Wang F; Liu S; Liu F; Xu T; Ma J; Liang J; Wang J; Liu D; Yang F; Li J; Xing N
Cancer Lett; 2023 Aug; 568():216300. PubMed ID: 37414394
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.
Xu F; Sunderland A; Zhou Y; Schulick RD; Edil BH; Zhu Y
Cancer Immunol Immunother; 2017 Oct; 66(10):1367-1375. PubMed ID: 28623459
[TBL] [Abstract][Full Text] [Related]
16. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
Yu J; Wei M; Becknell B; Trotta R; Liu S; Boyd Z; Jaung MS; Blaser BW; Sun J; Benson DM; Mao H; Yokohama A; Bhatt D; Shen L; Davuluri R; Weinstein M; Marcucci G; Caligiuri MA
Immunity; 2006 May; 24(5):575-90. PubMed ID: 16713975
[TBL] [Abstract][Full Text] [Related]
17. The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodies.
Stein N; Tsukerman P; Mandelboim O
Hum Antibodies; 2017; 25(3-4):111-119. PubMed ID: 28035916
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of TIGIT and PD-1 expression on NK cells during the course of normal pregnancy.
Wang Y; Li D; Yu T; Hu M; Xing J; Bai S; Qu W; Tong X
Immunol Lett; 2021 Feb; 230():42-48. PubMed ID: 33359535
[TBL] [Abstract][Full Text] [Related]
19. TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.
Maas RJ; Hoogstad-van Evert JS; Van der Meer JM; Mekers V; Rezaeifard S; Korman AJ; de Jonge PK; Cany J; Woestenenk R; Schaap NP; Massuger LF; Jansen JH; Hobo W; Dolstra H
Oncoimmunology; 2020 Nov; 9(1):1843247. PubMed ID: 33224630
[TBL] [Abstract][Full Text] [Related]
20. T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.
Kong Y; Zhu L; Schell TD; Zhang J; Claxton DF; Ehmann WC; Rybka WB; George MR; Zeng H; Zheng H
Clin Cancer Res; 2016 Jun; 22(12):3057-66. PubMed ID: 26763253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
